CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · Agreement ended · Regulation FD disclosure
- 4 Option exercise EVP, COO acquired 3,666 shares (option exercise)
- 4 Option exercise SVP, GC, BD & Corp Affairs acquired 3,666 shares (option exercise)
- 4 Option exercise SVP, CFO acquired 1,583 shares (option exercise)
- 4/A Insider Changes in Ownership
- 4 Option exercise President and CEO acquired 9,582 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Option exercise President and CEO acquired 4,791 shares (option exercise)
- 4 Option exercise CFO acquired 1,834 shares (option exercise)
- 8-K Event Other events
- 8-K Event Other events
Page 17 of 38 · 743 filings